Latigo Biotherapeutics LTGO
$13.00 −$0.24 (-1.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.00 0.00%
Open$13.22
Prev close$13.24
Day range$11.91 – $13.35
Volume267.2K
Market cap$861.89M
P/E (TTM)–
Dividend yield–
LTGO Stock News
Headlines matching Latigo Biotherapeutics or the LTGO ticker, most recent first.
- Goldman Sachs Maintains Latigo Biotherapeutics(LTGO.US) With Buy Rating, Maintains Target Price $73
- Guggenheim Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50
- Jefferies Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50
- Analysts Offer Insights on NA Companies: Latigo Biotherapeutics, Inc. (LTGO), Golar LNG (GLNG) and Mobility Global Inc (MBGL)
- Goldman Sachs Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $73
- Guggenheim Maintains Latigo Biotherapeutics(LTGO.US) With Buy Rating, Maintains Target Price $50
No comments yet — be the first to weigh in on LTGO.
Sign in to join the discussion.